Seeing the unseen: a late-onset Griscelli Syndrome Type 2 in a child without hypopigmentation
Open Access
- 29 March 2026
- journal article
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 7 (1) , 81-83
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Hemophagocytic lymphohistiocytosis: an update in diagnostics, criteria, and treatment considerationsCurrent Opinion in Pediatrics, 2025
- Griscelli Syndrome Type 2: Comprehensive Analysis of 149 New and Previously Described Patients with RAB27A DeficiencyJournal of Clinical Immunology, 2024
- Novel RAB27A Variant Associated with Late-Onset Hemophagocytic Lymphohistiocytosis Alters Effector Protein BindingJournal of Clinical Immunology, 2022
- Griscelli Syndrome Type 2 Sine Albinism: Unraveling Differential RAB27A Effector EngagementFrontiers in Immunology, 2020
- Genetic diseases predisposing to HLH2020
- Considering immunologic and genetic evaluation for HLH in neuroinflammation: A case of Griscelli syndrome type 2 with neurological symptoms and a lack of albinismPediatric Blood & Cancer, 2020
- Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte SocietyThe Journal of Allergy and Clinical Immunology: In Practice, 2018
- A RAB27A 5′ untranslated region structural variant associated with late-onset hemophagocytic lymphohistiocytosis and normal pigmentationJournal of Allergy and Clinical Immunology, 2018
- Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 bindingJournal of Allergy and Clinical Immunology, 2015